Literature DB >> 8884546

The 1996 report of a World Health Organization expert committee on hypertension control.

J Chalmers, A Zanchetti.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8884546

Source DB:  PubMed          Journal:  J Hypertens        ISSN： 0263-6352            Impact factor:   4.844


× No keyword cloud information.
  9 in total

Review 1.  Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.

Authors:  C J Dunn; A P Lea; A J Wagstaff
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

Review 2.  Nebivolol in the management of essential hypertension: a review.

Authors:  W McNeely; K L Goa
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

Review 3.  Irbesartan. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the management of hypertension.

Authors:  J C Gillis; A Markham
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

Review 4.  Candesartan cilexetil. A review of its use in essential hypertension.

Authors:  K J McClellan; K L Goa
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

Review 5.  Urapidil. A reappraisal of its use in the management of hypertension.

Authors:  M Dooley; K L Goa
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

6.  Antihypertensive prescribing practices: impact of the antihypertensive and lipid-lowering treatment to prevent heart attack trial.

Authors:  Marty S Player; James M Gill; Heather Bittner Fagan; Arch G Mainous
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-12       Impact factor: 3.738

7.  Knowledge and Practice of PHC Physicians toward the Detection and Management of Hypertension and Other CVD Risk Factors in Egypt.

Authors:  Mostafa A Abolfotouh; Laila A Soliman; Sameh M Abolfotouh; Mohamed Raafat
Journal:  Int J Hypertens       Date:  2011-08-11       Impact factor: 2.420

8.  Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: a pharmacoeconomic comparison of antihypertensive efficacy of beta blockers.

Authors:  Rachna S Patel; Kamal H Sharma; Nitisha A Kamath; Nirav H Patel; Ankita M Thakkar
Journal:  Indian J Pharmacol       Date:  2014 Sep-Oct       Impact factor: 1.200

9.  Does being under treatment improve knowledge attitude practice for hypertension: A hospital-based study from North India.

Authors:  Rajiv Kumar Gupta; Shahid Hussain; Zahida Parveen; Sunil Kumar Raina; Bhavna Langer; Rashmi Kumari
Journal:  J Family Med Prim Care       Date:  2017 Apr-Jun
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.